Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.19 by 5.26 percent. This is unchanged from the same period last year. The company reported quarterly sales of $997.000 million which beat the analyst consensus estimate of $950.920 million by 4.85 percent. This is a 8.38 percent increase over sales of $919.880 million the same period last year.